Diverse NACDS-backed provisions would enhance patients’ access to OTC hearing aids and to biosimilar and generic medications, and would maintain flexibility in drug disposal options.
Late last week, NACDS participated in a listening session with FDA Commissioner Califf and a handful of stakeholder groups to discuss on the ground insights regard the infant supply formula shortage.
On Monday, Dr. Kavita Patel, former White House policy director and fellow at the Brookings Institution, joined Becky Quick and Andrew Ross Sorkin of CNBC’s ‘Squawk Box’ to discuss pediatric COVID vaccines.
Appreciates the recognition of pharmacies’ need to plan ahead to be ready should the FDA and CDC authorize COVID shots for this age group.
In an historic move last week, the Food and Drug Administration (FDA) approved Semglee (insulin glargine-yfgn) as the first interchangeable biosimilar product.
The leaders of 18 pharmacy organizations issued a statement following the Food and Drug Administration’s approval of the first Emergency use Authorization for the COVID-19 vaccine.
